Clinical trial
Biomarker in Congenital Cardiac Surgery - sST2 Marker in Heart Failure in Congenital Heart Disease After Surgery Research and Translational Study
NCT07029230 is registered in ClinicalTrials.gov with Martin Schweiger as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Biomarker in Congenital Cardiac Surgery - sST2 Marker in Heart Failure in Congenital Heart Disease After Surgery Research and Translational Study
- Lead sponsor
- Martin Schweiger
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- September 10, 2025
- Completion date
- January 31, 2029
- Enrollment
- 225 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
congenital heart disease in children, congenital heart surgery, fontan physiology